辽宁依生生物制药有限公司 Alternatives & Competitors

12 companies similar to 辽宁依生生物制药有限公司 — Pioneering groundbreaking biotherapeutics for cancers and infectious diseases wi...

VentiRx Pharmaceuticals

Advancing healthcare innovations with targeted therapies for cancer, respiratory, and auto...

Series B $104.50M

Biotechnology Health Care +1

Compare

VBI Vaccines Inc.

Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease

57 Post-IPO Equity $186.24M

Cambridge, United States

Biotechnology Health Care

Compare

Carisma Therapeutics

Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors

15 Acquired $101.00M

Philadelphia, United Stat...

Biotechnology Health Care +2

Genelabs Technologies

24 Venture round $17.30M

Biopharma Biotechnology +2

Track all 辽宁依生生物制药有限公司 competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Tetralogic Pharmaceuticals

10 Convertible Note $164.00M

Biotechnology Health Care +1

MetiMedi Co., Ltd.

MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...

Korea South

Biotechnology Health Care

AltruBio Inc.

Novel Therapeutics for Immunological Diseases

28 Series B $327.61M

San Francisco, United Sta...

Biotechnology Health Care

Epsilogen Ltd

Harnessing the power of IgE

33 Series B $39.95M

United Kingdom

Biopharma Biotechnology +2

SOLID Therapeutics

An early-stage oncology company aiming to treat solid tumors

Denmark

Greywolf Therapeutics

We are advancing novel antigen modulation technology that controls T cells to guide the im...

49 Series B $107.10M

United Kingdom

Biotechnology Health Care +1

IMMUNITOR Ltd.

Immunitor's proprietary technology enables us to formulate any vaccine as an oral pill.

Winchester, United Kingdo...

Biotechnology Health Care +1

Hercules Pharmaceuticals

Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid...

Seed $300.00K

Biopharma Biotechnology

About 辽宁依生生物制药有限公司

辽宁依生生物制药有限公司 (YS Biopharma), founded in 2002, is a pioneering biopharmaceutical firm specializing in the development of innovative biotherapeutics for cancers and infectious diseases. Their signature PIKA® immunomodulating technology sets them apart in the industry, enhancing both innate and adaptive immune...

Business keywords

Biopharmaceutical, Biotherapeutics, Cancer Treatment, Infectious Diseases, Immunomodulating Technology, TLR3 Pathway, RIG-I Pathway, MDA5 Pathway, Solid Tumors, Hepatitis B Vaccine, Rabies Vaccine, Global Biopharmaceutical Company, Clinical Development Products, Novel Immunomodulating Technology

Frequently Asked Questions

Companies similar to 辽宁依生生物制药有限公司 include VentiRx Pharmaceuticals, VBI Vaccines Inc., Carisma Therapeutics, Genelabs Technologies, Tetralogic Pharmaceuticals. They work in Biotechnology and Health Care and share 辽宁依生生物制药有限公司's focus on cancer treatment, solid tumors and biopharmaceutical.

Bounce Watch lists 12 companies that share 辽宁依生生物制药有限公司's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches 辽宁依生生物制药有限公司 and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

辽宁依生生物制药有限公司 Profile Carisma Therapeutics Alternatives Genelabs Technologies Alternatives Tetralogic Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at 辽宁依生生物制药有限公司 on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.